MATINAS BIOPHARMA HOLDINGS, INC. Accounts Payable
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) had Accounts Payable of $845.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-13
- 2026-06-30: Accounts Payable, Current $845.00K.
- 2026-03-31: Accounts Payable, Current $712.00K.
- 2025-12-31: Accounts Payable, Current $315.00K.
- 2025-09-30: Accounts Payable, Current $80.00K.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $845.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $712.00K 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $315.00K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $80.00K 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $167.00K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $282.00K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $95.00K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $349.00K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $238.00K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $473.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $514.00K 10-K · filed 2025-04-15 | |
| 2023-09-30 | $835.00K 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $604.00K 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $516.00K 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $618.00K 10-K · filed 2024-03-27 | |
| 2022-09-30 | $656.72K 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $497.15K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $1.35M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $937.00K 10-K · filed 2023-03-15 | $938.27K 10-K · filed 2022-03-08 |
| 2021-09-30 | $662.00K 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $450.46K 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $421.64K 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $349.94K 10-K/A · filed 2022-03-11 | |
| 2020-09-30 | $373.07K 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $494.58K 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $953.33K 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $679.31K 10-K · filed 2021-03-29 | |
| 2019-09-30 | $685.80K 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $548.13K 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $394.69K 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $295.65K 10-K · filed 2020-03-09 | |
| 2018-09-30 | $303.36K 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $497.39K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $473.51K 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $582.87K 10-K · filed 2019-04-01 | |
| 2017-09-30 | $341.59K 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $453.22K 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $1.25M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $475.60K 10-K · filed 2018-03-16 | |
| 2016-09-30 | $209.46K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $475.86K 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $620.56K 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $497.84K 10-K · filed 2017-03-31 | |
| 2015-09-30 | $282.10K 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $745.55K 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $466.62K 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $271.15K 10-K · filed 2016-03-30 | |
| 2014-09-30 | $211.83K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $281.09K 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $242.33K 10-Q · filed 2014-06-06 | |
| 2013-12-31 | $396.77K 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |